Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Academic Article RDF

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • more...
  • 5-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity
  • 5-aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor alpha-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independent
  • 5-Azido neuraminic acid thioglycoside as sialylation donor
  • 5-HT receptor classification and nomenclature: Towards a harmonization with the human genome
  • 5-HT receptor nomenclature: Naming names, does it matter? A tribute to Maurice Rapport
  • 5-HT(1A) receptor activation: short-term effects on the mRNA expression of the 5-HT(1A) receptor and galanin in the raphe nuclei
  • 5-HT(1A) receptor binding in the dorsal raphe nucleus is implicated in the anxiolytic-like effects of Cinnamomum cassia
  • 5-ht(1a) receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups
  • 5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission
  • 5-HT(2C) agonists as therapeutics for the treatment of schizophrenia
  • 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine
  • 5-HT(7) receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
  • 5-HT1A autoreceptors in the dorsal raphe nucleus convey vulnerability to compulsive cocaine seeking
  • 5-HT2C receptor structures reveal the structural basis of GPCR polypharmacology
  • 5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfany l-1- 4-(5-methoxy-pyrimidin-2-yl)-benzyl -1H-indol-2-yl}-2,2-dimethyl-pr opionic acid (AM679)-A potent FLAP inhibitor
  • 5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103)
  • 5-N,4-O-carbonyl-7,8,9-tri-O-chloroacetyl-protected sialyl donor for the stereoselective synthesis of alpha-(2-->9)-tetrasialic acid
  • 5S rRNA gene transcription factor IIIA alters the helical configuration of DNA
  • 6,7-dihydroxyisoquinoline-3-carboxylic acids are potent inhibitors on the binding of insulin-like growth factor (IGF) to IGF-binding proteins: Optimization of the 1-position benzoyl side chain
  • 6,8-di-C-glycosyl flavonoids from Dendrobium huoshanense
  • 6,9-pyridazaprostacyclin and derivatives: the first "aromatic" prostacyclins
  • 6,9-thiaprostacyclin. A stable and biologically potent analogue of prostacyclin (PGI2)
  • 6-alkynyl fucose is a bioorthogonal analog for O-fucosylation of epidermal growth factor-like repeats and thrombospondin Type-1 repeats by protein O-fucosyltransferases 1 and 2
  • 6-Deoxyerythronolide B synthase thioesterase-catalyzed macrocyclization is highly stereoselective
  • 6-endo-hydroxy-3-endo-aminomethylbicyclo[2.2.1]heptane-2-endo-carboxylic acid lactam
  • 6-substituted hexamethylene amiloride (HMA) derivatives as potent and selective inhibitors of the human urokinase plasminogen activator for use in cancer
  • 68Ga-PSMA-11 PET imaging of response to androgen receptor inhibition: first human experience
  • 7-alkylidenecephalosporin esters as inhibitors of human leukocyte elastase
  • 7-Chlorokynurenate Ameliorates Neuronal Injury Mediated by HIV Envelope Protein gp120 in Rodent Retinal Cultures
  • 7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • more...

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support